Cargando…

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape

Ovarian cancer (OC) is still the leading cause of death among all gynecological malignancies, despite the recent progress in cancer therapy. Immune escape and drug resistance, especially platinum-based chemotherapy, are significant factors causing disease progression, recurrence and poor prognosis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Xueqin, Zhao, Yangjing, Liang, Xiuting, Wang, Hui, Zhu, Yanling, Shao, Qixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047328/
https://www.ncbi.nlm.nih.gov/pubmed/33868274
http://dx.doi.org/10.3389/fimmu.2021.641937
_version_ 1783679028029292544
author Zou, Xueqin
Zhao, Yangjing
Liang, Xiuting
Wang, Hui
Zhu, Yanling
Shao, Qixiang
author_facet Zou, Xueqin
Zhao, Yangjing
Liang, Xiuting
Wang, Hui
Zhu, Yanling
Shao, Qixiang
author_sort Zou, Xueqin
collection PubMed
description Ovarian cancer (OC) is still the leading cause of death among all gynecological malignancies, despite the recent progress in cancer therapy. Immune escape and drug resistance, especially platinum-based chemotherapy, are significant factors causing disease progression, recurrence and poor prognosis in OC patients. MicroRNAs(miRNAs) are small noncoding RNAs, regulating gene expression at the transcriptional level. Accumulating evidence have indicated their crucial roles in platinum resistance. Importantly, they also act as mediators of tumor immune escape/evasion. In this review, we summarize the recent study of miRNAs involved in platinum resistance of OC and systematically analyses miRNAs involved in the regulation of OC immune escape. Further understanding of miRNAs roles and their possible mechanisms in platinum resistance and tumor escape may open new avenues for improving OC therapy.
format Online
Article
Text
id pubmed-8047328
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80473282021-04-16 Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape Zou, Xueqin Zhao, Yangjing Liang, Xiuting Wang, Hui Zhu, Yanling Shao, Qixiang Front Immunol Immunology Ovarian cancer (OC) is still the leading cause of death among all gynecological malignancies, despite the recent progress in cancer therapy. Immune escape and drug resistance, especially platinum-based chemotherapy, are significant factors causing disease progression, recurrence and poor prognosis in OC patients. MicroRNAs(miRNAs) are small noncoding RNAs, regulating gene expression at the transcriptional level. Accumulating evidence have indicated their crucial roles in platinum resistance. Importantly, they also act as mediators of tumor immune escape/evasion. In this review, we summarize the recent study of miRNAs involved in platinum resistance of OC and systematically analyses miRNAs involved in the regulation of OC immune escape. Further understanding of miRNAs roles and their possible mechanisms in platinum resistance and tumor escape may open new avenues for improving OC therapy. Frontiers Media S.A. 2021-04-01 /pmc/articles/PMC8047328/ /pubmed/33868274 http://dx.doi.org/10.3389/fimmu.2021.641937 Text en Copyright © 2021 Zou, Zhao, Liang, Wang, Zhu and Shao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zou, Xueqin
Zhao, Yangjing
Liang, Xiuting
Wang, Hui
Zhu, Yanling
Shao, Qixiang
Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
title Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
title_full Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
title_fullStr Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
title_full_unstemmed Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
title_short Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
title_sort double insurance for oc: mirna-mediated platinum resistance and immune escape
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047328/
https://www.ncbi.nlm.nih.gov/pubmed/33868274
http://dx.doi.org/10.3389/fimmu.2021.641937
work_keys_str_mv AT zouxueqin doubleinsuranceforocmirnamediatedplatinumresistanceandimmuneescape
AT zhaoyangjing doubleinsuranceforocmirnamediatedplatinumresistanceandimmuneescape
AT liangxiuting doubleinsuranceforocmirnamediatedplatinumresistanceandimmuneescape
AT wanghui doubleinsuranceforocmirnamediatedplatinumresistanceandimmuneescape
AT zhuyanling doubleinsuranceforocmirnamediatedplatinumresistanceandimmuneescape
AT shaoqixiang doubleinsuranceforocmirnamediatedplatinumresistanceandimmuneescape